Catalyst Pharmaceuticals, Inc.CPRXNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank64
3Y CAGR-21.7%
5Y CAGR+15.0%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-21.7%/yr
vs -61.9%/yr prior
5Y CAGR
+15.0%/yr
Recent deceleration
Acceleration
+40.2pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
2x
Strong expansion
Streak
3 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.65 | -8.4% |
| 2024 | 3.98 | -4.1% |
| 2023 | 4.15 | -45.4% |
| 2022 | 7.60 | +101.0% |
| 2021 | 3.78 | +108.9% |
| 2020 | 1.81 | -37.8% |
| 2019 | 2.91 | -99.2% |
| 2018 | 361.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |